newsfilter
← Latest News
GlobeNewswire·

Sigyn Therapeutics Announces First-In-Human Clinical Strategy to Address Inflammation and Endotoxemia in End-Stage Renal Disease Patients

SAN DIEGO, CA, Sept. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTCQB:SIGY), a development-stage company focused on the creation of therapeutic solutions that address unmet needs in global health, announced today that i